Abby Abraham

Abby Abraham, Vice President, Data Analytics, and RBM for OmniComm Systems, writes about a new survey that highlights gaps in the conversation surrounding the industry’s adoption and implementation of risk-based approaches to monitoring.

Case study demonstrates how one global mid-sized sponsor is testing the RBM waters.

Risk-based approaches to monitoring (RBM) have become widely accepted in the clinical trials industry.

This case study examines using centralized manual data review with statistical approaches to compare value and fit.